Oliver Zivanovic

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

S. Dennis, Eric Eisenhauer, Oliver Zivanovic et al. · Gynecologic Oncology · 2009 · 596 citations

Medicine, Oncology, Surgery +16

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient

Alejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe et al. · Cell · 2017 · 463 citations · Full text

Medicine, Immunology, Oncology +17

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Dmitriy Zamarin, Robert A. Burger, Michael W. Sill et al. · Journal of Clinical Oncology · 2020 · 351 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Ovarian cancer mutational processes drive site-specific immune evasion

Ignacio Vázquez-Garćıa, Florian Uhlitz, Nicholas Ceglia et al. · Nature · 2022 · 307 citations · Full text

Medicine, Immunology, Oncology +17

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

S. Dennis, Fernanda Musa, Fanny Dao et al. · Gynecologic Oncology · 2011 · 272 citations

Medicine, Oncology, Surgery +12